MedPath

Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease

Not Applicable
Active, not recruiting
Conditions
Chronic Graft-Versus-Host Disease
Quality of Life
Registration Number
NCT06688942
Lead Sponsor
University of Miami
Brief Summary

The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Underwent allogeneic hematopoietic stem cell transplant
  • Have moderate to severe chronic graft-versus-host disease
  • Currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program
  • Able to use an Ipad to participate in the Horizons app intervention
  • Able to participate in study procedures in English
Exclusion Criteria
  • comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
  • Vulnerable patients, defined here as prisoners and pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Percentage of participant enrollmentUp to 8-week follow-up

Participant enrollment will be demonstrated if ≥60% eligible participants enroll.

Percentage of participant retentionUp to 8-week follow-up

Participant retention will be demonstrated if ≥80% participants are retained in the study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath